You are here

Program Outcomes

Upon completion of the Wadsworth Center Master of Science in Laboratory Sciences (MLS) program, graduates will:

  • Demonstrate knowledge of the practical applications of a broad range of laboratory science. Major areas of study include, but are not limited to: clinical and environmental chemistry, immunology, microbiology and infectious disease, molecular diagnostics, newborn screening, and other emerging areas involving public health laboratory science;
  • Play a leading role in the development and evaluation of test systems and interpretative algorithms;
  • Communicate effectively to enable consultative interactions with members of the public health community and provide customer service and patient education;
  • Gain basic knowledge of laboratory operations and management, and be familiar with state and federal regulatory guidance, best practices and quality assurance compliance;
  • Evaluate information management systems to enable effective, timely, accurate, and cost-effective reporting of laboratory-generated information.

After completing the MLS Program, graduates have found employment at the Centers for Disease Control and Prevention (CDC), the New York City Department of Health, the New York State Department of Health (Wadsworth Center), and have enrolled in doctoral degree programs. MLS graduates have also been selected for Emerging Infectious Diseases (EID) fellowships sponsored by the Association of Public Health Laboratories (APHL) and CDC, Advanced Molecular Detection (AMD) fellowships and Oak Ridge Institute for Science and Education (ORISE) fellowships sponsored by the CDC.

Peer-reviewed publications by MLS students:

Perry M, Centurioni D, Davis S, Hannett G, Musser K, Egan C. Implementing the Bruker MALDI Biotyper in the Public Health Laboratory for C. botulinum Neurotoxin Detection. Toxins (Basel). 2017;9(3):94. Read more

Lin N, Huang J, Violante S, Orsini JJ, Caggana M, Hughes EE, Stevens C, DiAntonio L, Liao HC, Hong X, et al. Liquid Chromatography-Tandem Mass Spectrometry Assay of Leukocyte Acid α-Glucosidase for Post-Newborn Screening Evaluation of Pompe Disease. Clin Chem. 2017:clinchem.2016.259036. Read more

Hughes EE, Stevens CF, Saavedra-Matiz CA, Tavakoli NP, Krein LM, Parker A, Zhang Z, Maloney B, Vogel B, DeCelie-Germana J, et al. Clinical sensitivity of cystic fibrosis mutation panels in a diverse population. Hum Mutat. 2016;37(2):201–208. Read more

Lapierre P, Halse TA, Shea J, Escuyer VE, Musser KA. Draft Genome Sequence of Branchiibius sp. NY16-3462-2, Isolated from a Mixed Clinical Sample. Genome Announc. 2016;4(3).  Read more

McGinnis J, Laplante J, Shudt M, George K St. Next generation sequencing for whole genome analysis and surveillance of influenza A viruses. J Clin Virol. 2016;79:44-50. Read more

McGinnis J, Cole J, Dickinson M, Mingle L, Lapierre P, Musser K, Wolfgang W. Paracoccus sanguinis sp. nov., isolated from clinical specimens of New York State patients. Int J Syst Evol Microbiol. 2015;65(6):1877-1882. Read more

Krizova L, McGinnis J, Maixnerova M, et al. Acinetobacter variabilis sp. nov. (formerly DNA group 15 sensu Tjernberg & Ursing), isolated from humans and animals. Int J Syst Evol Microbiol. 2015;65(Pt 3):857-863. Read more

Zhu YC, Mitchell KK, Nazarian EJ, Escuyer VE, Musser KA. Rapid prediction of inducible clarithromycin resistance in Mycobacterium abscessus. Mol Cell Probes. 2015;29(6):514-516. Read more